China Jo-Jo Drugstores, Inc.

CJJD

KYG2124G1203

Drug Retailers

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.834 ^USD	+0.14%		-0.91%	-36.17%

Mar. 20	China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023	CI
Mar. 05	Top Premarket Gainers	MT

China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022

July 28, 2022 at 09:00 am EDT

China Jo-Jo Drugstores, Inc. reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was USD 164.39 million compared to USD 133.13 million a year ago. Net loss was USD 3.19 million compared to USD 8.12 million a year ago. Basic loss per share from continuing operations was USD 0.92 compared to USD 2.39 a year ago. Diluted loss per share from continuing operations was USD 0.92 compared to USD 2.39 a year ago.

Latest news about China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023	Mar. 20	CI
Top Premarket Gainers	Mar. 05	MT
China Jo-Jo Drugstores, Inc. Appoints Caroline Wang as Directors	Feb. 26	CI
China Jo-Jo Drugstores Receives Non-Compliance Notice From Nasdaq	23-06-20	MT
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-15	CI
Top Midday Gainers	23-04-19	MT
Sector Update: Consumer Stocks Edging Up Late Tuesday	23-04-18	MT
Top Midday Decliners	23-04-18	MT
Sector Update: Consumer Stocks Little Changed Tuesday Afternoon	23-04-18	MT
China Jo-Jo Drugstores Strikes Deal to Sell $7 Million Securities - Shares Slump	23-04-18	MT
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Half Year Ended September 30, 2022	23-01-20	CI
China Jo-Jo Drugstores Launches $2.6 Million Direct Offering; Shares Fall	23-01-20	MT
Wall Street Set to Open Higher as Earnings Season Accelerates, Ahead of Consumer Sentiment Survey	22-10-14	MT
US Stock Futures Mixed as Earnings Season Accelerates, Ahead of Consumer Sentiment Survey	22-10-14	MT
Top Premarket Decliners	22-10-14	MT
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-28	CI
China Jo-Jo Drugstores Regains Compliance With Nasdaq's Minimum Bid Price Rule	22-04-27	MT
Top Premarket Decliners	22-04-12	MT
China Jo-Jo Drugstores to Implement 1-for-12 Reverse Stock Split	22-04-06	MT
China Jo-Jo Drugstores Receives Extension to Cure Minimum Bid Price Deficiency	22-01-26	MT
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Half Year Ended September 30, 2021	22-01-21	CI
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Full Year Ended March 31, 2021	21-06-29	CI
China Jo Jo Drugstores : Earnings Flash (CJJD) CHINA JO-JO DRUGSTORES Posts Q3 Revenue $35.5M	21-02-12	MT
China Jo-Jo Drugstores, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-02-12	CI
China Jo Jo Drugstores : Regains Compliance With Nasdaq's Listing Requirement	20-12-23	MT

Chart China Jo-Jo Drugstores, Inc.

Duration

Period

More charts

Company Profile

China Jo-Jo Drugstores Inc, formerly China Jo-Jo Drugstores Holdings Inc, is a China-based retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.

Sector

Drug Retailers

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
CHINA JO-JO DRUGSTORES, INC.	-36.17%	6.13M
JD HEALTH INTERNATIONAL INC.	-31.97%	10.84B
YIFENG PHARMACY CHAIN CO., LTD.	+8.14%	6.04B
MATSUKIYOCOCOKARA & CO.	-11.41%	5.86B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-30.42%	6.06B
NAHDI MEDICAL COMPANY	-0.88%	4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+52.19%	4.29B
CLICKS GROUP LIMITED	-12.31%	3.61B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-14.86%	3.33B
WELCIA HOLDINGS CO., LTD.	-6.93%	3.01B